153
Participants
Start Date
September 2, 2024
Primary Completion Date
November 7, 2024
Study Completion Date
March 30, 2025
Group 1 will include patients aged 18-40 years
Group 1 will include patients aged 18-40 years.
Group 2 will include patients aged 40-64 years
Group 2 will include patients aged 40-64 years, and finally.
Group 3 will include patients aged 65-85 years
Group 3 will include patients aged 65-85 years.
Zeynep Koç, Yenimahalle
Diskapi Yildirim Beyazit Education and Research Hospital
OTHER_GOV